Physician profile
Tzvi Small
NPI 1033188461
$1,512.71
in general payments reported to CMS, 2019-2025
14 companies · $277 in 2025
The $277 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.58 · 2020: $14.44 · 2021: $29.87 · 2022: $298 · 2023: $62.07 · 2024: $762 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $299.27 | 2024 | Hemoblast Bellows |
| Checkpoint Surgical, INC | $197.71 | 2022 | |
| Kerecis Limited | $190.95 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Allergan, INC. | $184.72 | 2019-2022 | |
| Sanara Medtech INC. | $143.12 | 2024 | Celleraterx |
| Abbvie INC. | $126.14 | 2023-2025 | Alloderm |
| Tactile Systems Technology INC | $111.66 | 2024 | Entre Plus, Flexitouch Plus |
| Seapearl East, INC | $100.00 | 2024 | |
| Axogen | $68.14 | 2025 | |
| Biowound Solutions, INC. | $29.13 | 2025 | Bio-Connekt |
| Galderma Laboratories, L.P. | $17.08 | 2024 | Dysport |
| Convatec INC. | $16.18 | 2024 | |
| Kci USA, INC. | $14.44 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $14.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tzvi Small listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.